Research Topics
Genomes and GenesSpecies | K PantelSummaryAffiliation: University of Hamburg Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Clinical relevance and biology of circulating tumor cellsNatalia Bednarz-Knoll
Department of Tumour Biology, University Medical Centre Hamburg Eppendorf, Martinistr, 52, 20246 Hamburg, Germany
Breast Cancer Res 13:228. 2011..This review focuses on investigations regarding the biology and clinical relevance of circulating tumor cells in breast cancer...
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancerVolkmar Muller
Department of Gynecology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20241 Hamburg, Germany
Breast Cancer Res 13:R71. 2011..The aim of the study was to investigate whether serum concentrations of TIMP-1 and CAIX are associated with the detection of CTC in metastatic breast cancer...
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancerCarina Roth
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Breast Cancer Res 12:R90. 2010..Here we evaluated, for the first time, the feasibility and clinical utility of circulating miRs as biomarkers for the detection and staging of breast cancer...
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancerHeidi Schwarzenbach
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Breast Cancer Res 9:R66. 2007..The aim of the study was to perform a comparative analysis of LOH (loss of heterozygosity) in primary tumors as well as peripheral blood and bone marrow (BM) of patients with breast cancer (BCa)...
Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevanceTanja Fehm
Department of Gynecology and Obstetrics, University Tübingen, Tubingen, Germany
Breast Cancer Res 10:S1. 2008..In addition, understanding tumor 'dormancy' and identifying metastatic stem cells might result in the development of new therapeutic concepts...
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancerHeidi Schwarzenbach
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, Hamburg, 20246, Germany
Breast Cancer Res 11:R71. 2009..Here we investigated whether the detection of this DNA is related to bone marrow (BM) micrometastasis and tumor recurrence in breast cancer patients...
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progressionCarina Roth
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Germany
BMC Cancer 11:4. 2011....
Cancer micrometastasesKlaus Pantel
Institute of Tumour Biology, Center of Experimental Medicine, University Medical Center Hamburg Eppendorf, Martinistrasse 52, Hamburg, Germany
Nat Rev Clin Oncol 6:339-51. 2009..This Review focuses on the clinical relevance of the latest research results on blood-borne cancer micrometastases in patients with cancer...
Detection and clinical implications of early systemic tumor cell dissemination in breast cancerKlaus Pantel
Institut für Tumorbiologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 9:6326-34. 2003..Here, we will review the existing tumor cell assays and discuss their current clinical relevance and perspectives for the clinical management of breast cancer patients...
Detection, clinical relevance and specific biological properties of disseminating tumour cellsKlaus Pantel
Institute of Tumour Biology, Center of Experimental Medicine, University Medical Center Hamburg Eppendorf, Martinistrasse 52, Hamburg, Germany
Nat Rev Cancer 8:329-40. 2008..Here we review the evidence that disseminating tumour cells have a variety of uses for understanding tumour biology and improving cancer treatment...
[Minimal residual disease in breast cancer: detection and clinical relevance]K Pantel
Institut für Tumorbiologie, Zentrum für Experimentelle Medizin Hamburg Eppendorf, Deutschland
Verh Dtsch Ges Pathol 89:68-75. 2005..In this review, we will therefore discuss the detection, characterisation and clinical relevance of DTC...
Detection and molecular characterisation of disseminated tumour cells: implications for anti-cancer therapyKlaus Pantel
Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Center Hamburg, Eppendorf, Martinistr 52, 20246 Hamburg, Germany
Biochim Biophys Acta 1756:53-64. 2005..In this review, we will therefore discuss the detection and characterisation of DTC in the light of new therapeutic strategies targeting tumour-associated molecules and signalling pathways...
Micrometastasis in breast cancer and other solid tumorsK Pantel
Institute of Tumor Biology, University Hospital Hamburg Eppendorf, Hamburg, Germany
J Biol Regul Homeost Agents 18:120-5. 2004..Thus, dissemination of tumor cells appears to be an early process associated with a specific molecular signature of the primary tumor...
The clinical significance of circulating tumor cellsKlaus Pantel
Institute of Tumor Biology, University Medical Center, Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
Nat Clin Pract Oncol 4:62-3. 2007
Dissecting the metastatic cascadeKlaus Pantel
Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg 202461, Germany
Nat Rev Cancer 4:448-56. 2004
Identification and characterisation of minimal residual disease in solid tumorsK Pantel
Department of Molecular Diagnostics and Therapy, University Hospital Eppendorf, Martinistrasse 52, D 20246 Hamburg, Germany
Acta Med Austriaca Suppl 52:8-12. 2000..For the first time these methods give access to this critical stage of tumor progression and also contribute to the development of new approaches to therapy aimed at preventing manifest metastasis...
Circulating tumour cells in cancer patients: challenges and perspectivesKlaus Pantel
Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
Trends Mol Med 16:398-406. 2010..Moreover, molecular analyses of CTCs/DTCs have provided new insights into the biology of metastasis with important implications for the clinical management of cancer patients...
Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cellsK Pantel
Molekulare Onkologie, Frauenklinik, Universitäts Klinikum Eppendorf, Martinistrasse 52, D 20246 Hamburg, Germany
Semin Cancer Biol 11:327-37. 2001..Taken together, the advancing characterization of disseminated tumour cells opens the avenue for the development of new therapeutic approaches aimed at preventing metastatic relapse...
Molecular determinants of occult metastatic tumor cells in bone marrowK Pantel
Universitats Frauenklinik, Universitätsklinikum Eppendorf, Martinistrasse 52, D 20246 Hamburg, Germany
Clin Breast Cancer 2:222-8. 2001..This review summarizes the current knowledge of the biological characteristics of micrometastatic cancer cells in bone marrow of breast cancer patients...
Molecular profiling of micrometastatic cancer cellsK Pantel
Department of Molecular Oncology, University Women s Clinic, University Hospital Eppendorf, Hamburg, Germany
Ann Surg Oncol 8:18S-21S. 2001..These methods not only can identify this critical stage of tumor progression but also may facilitate the development of therapies to prevent manifest metastasis...
Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancerI Witzel
Department of Gynecology, University Medical Center Hamburg-Eppendorf, Germany
Int J Biol Markers 21:131-40. 2006..In contrast, no such correlation was observed for EGFR...
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancerHeidi Schwarzenbach
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Germany
Int J Cancer 120:1465-71. 2007..These data demonstrate, for the first time, the presence of free tumor-specific DNA in blood and BM of PCa patients and suggest a possible relationship to BM micrometastasis...
MAGE-A gene expression pattern in primary breast cancerM Otte
Molekulare Onkologie, Frauenklinik, , Germany
Cancer Res 61:6682-7. 2001..Our findings suggests a potential involvement of MAGE-A in tumor progression, with potential implications for active immunotherapy...
Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junctionPaulus G Schurr
Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
J Surg Oncol 94:307-15. 2006..CONCLUSIONS: Lymphatic microinvolvement shows a high incidence in curatively resected EGJ cancer. Spread to mediastinal lymph nodes seems to necessitate lymphadenectomy of the thoracic cavity in either type...
Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapyEmre-F Yekebas
Department of General, Visceral and Thoracic Surgery, University Medical Centre of Hamburg-Eppendorf, Martinistrabe 52, 20246 Hamburg, Germany
World J Gastroenterol 12:6515-21. 2006..The addition of immunohistochemical findings to histopathology reports may help to improve risk stratification of patients with pancreatic cancer...
Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cellsNatalie Reimers
Institute of Tumor Biology, University Hospital Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 10:3422-8. 2004..We here evaluated whether EMMPRIN expression is related to tumor progression in human breast cancer...
Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cellsSabine Riethdorf
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Ann N Y Acad Sci 1210:66-77. 2010..This information might support assessing individual prognosis, stratifying patients at risk to systemic therapies, and monitoring therapeutic efficacy...
Review: Biological relevance of disseminated tumor cells in cancer patientsSabine Riethdorf
Institute of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Int J Cancer 123:1991-2006. 2008..Our review will focus on breast, colon, lung, and prostate cancer as the main tumor entities in Europe and the United States...
Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagusTatyana Kalinina
Department of General, Visceral and Thoracic Surgery, University Medical Center, Hamburg Eppendorf, Hamburg, Germany
Int J Cancer 127:1931-40. 2010..IGF-1R expression can be used as a novel prognostic marker for adenocarcinomas of the esophagus. Cotreatment with IGF-1R and HER2 antibodies might become a valuable and effective treatment option in esophageal adenocarcinoma...
Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patientsKai Bartkowiak
Institute for Tumor Biology, University Medical Center Hamburg Eppendorf, Martinistr 52, Hamburg, Germany
J Proteome Res 9:3158-68. 2010..Our results suggest the presence of a previously not recognized stress resistant DTC population that combines stem/progenitor attributes with an UPR phenotype...
Detection and clinical importance of micrometastatic diseaseK Pantel
K Pantel, Universitatsfrauenklinik, Universitätsklinikum Eppendorf, Hamburg, Germany
J Natl Cancer Inst 91:1113-24. 1999....
Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progressionJ W Kornfeld
Institute of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
Br J Cancer 104:138-45. 2011..TACE-dependent proteolysis is regulated by its inhibitor, tissue inhibitor of metalloproteinases 3 (TIMP3). This study analyses the role of TACE and TIMP3 mRNA expression in squamous cell carcinomas of the head and neck (HNSCCs)...
Characterization of disseminated tumor cellsS B Hosch
Chirurgische Klinik, , Hamburg, Germany
Semin Surg Oncol 20:265-71. 2001..This review summarizes the current knowledge on the biological characteristics of micrometastatic cancer cells in bone marrow and lymph nodes of cancer patients...
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trialSabine Riethdorf
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 16:2634-45. 2010..This study was aimed at detecting and characterizing circulating tumor cells (CTC) before and after neoadjuvant therapy (NT) in the peripheral blood of patients with breast cancer...
Insights into minimal residual disease in cancer patients: implications for anti-cancer therapiesVolkmar Muller
Department of Gynecology, University Breast Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Eur J Cancer 46:1189-97. 2010..In this article, we summarize the clinical background and the technical aspects of current methods used for the detection and characterization of DTC in BM and CTC in blood, with a special focus on breast cancer...
Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvementDean Bogoevski
Department of General, Visceral and Thoracic Surgery, University Medical Centre of Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
Ann Surg 240:993-1000; discussion 1000-1. 2004..This could be a helpful tool in proper selection of patients for adjuvant chemotherapy...
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancerFelix K-H Chun
Department of Urology, University Hospital Hamburg Epppendorf, Hamburg, Germany
BJU Int 98:544-8. 2006..The predictive accuracy was substantially increased by adding plasma DNA level. However, larger-scale studies are needed to further confirm its clinical impact on prostate cancer detection...
In vitro differentiation of endothelial cells from AC133-positive progenitor cellsU M Gehling
Department of Hematology Oncology, University Hospital Eppendorf, Hamburg, Germany
Blood 95:3106-12. 2000..Whether these hematopoietic and endothelial progenitors develop from a common precursor, the hemangioblast will be studied at the single-cell level...
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerM G Friedrich
Department of Urology, University Hospital Hamburg Eppendorf, University of Hamburg, Germany
BJU Int 92:911-4. 2003..g. loss at 9p21) using a multitarget fluorescence in situ hybridization (FISH) system, as identifying genetic alterations in urine specimens is a promising approach for the noninvasive detection of bladder cancer...
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatmentJens Kollermann
Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
J Clin Oncol 26:4928-33. 2008..To explore whether the presence of occult disseminated tumor cells (DTCs) in the bone marrow before neoadjuvant hormone therapy influences the prognosis of patients with organ confined prostate cancer treated by radical prostatectomy...
Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancerJussuf T Kaifi
Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
Am J Surg 194:380-4. 2007..Short tandem repeat (STR) polymorphisms in exon 4 of the esophageal cancer-related gene 2 (ECRG2) are a risk marker for esophageal carcinoma. The aim of the present study was to correlate these STRs with clinical outcome...
Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancerHeidi Schwarzenbach
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 15:1032-8. 2009..Circulating cell-free DNA in the blood of cancer patients harbors tumor-specific aberrations. Here, we investigated whether this DNA might also reflect the presence of circulating tumor cells (CTC)...
Strong impact of micrometastatic tumor cell load in patients with esophageal carcinomaAlexandra M Koenig
Department of General, Visceral and Thoracic Surgery, University Medical Centre of Hamburg Eppendorf, Germany
Ann Surg Oncol 16:454-62. 2009..To assess the role of immunohistochemically detectable nodal microinvolvement of patients with "curatively" resected esophageal carcinoma...
Detection and monitoring of cell-free DNA in blood of patients with colorectal cancerHeidi Schwarzenbach
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Ann N Y Acad Sci 1137:190-6. 2008..02). Quantitative analysis demonstrates that elevated DNA levels can be detected in blood of patients with colorectal cancer and may be a useful tool in combination with other tumor markers for detection of colorectal cancer...
Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancerHeidi Schwarzenbach
Institute of Tumour Biology, University Medical Centre, Hamburg Eppendorf, Germany
BJU Int 102:253-8. 2008..To investigate whether a high frequency of allelic imbalance (AI) is associated with clinicopathological variables of patients with prostate cancer...
Central mesenteric lymph node BER-Ep4+ cells in colorectal cancer: challenge to sentinel node concept?Paulus G Schurr
Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Dig Surg 24:19-27. 2007..The role of sentinel lymph nodes in colorectal cancer remains unclear...
Molecular analysis of the polymorphisms of thymidylate synthase on cell-free circulating DNA in blood of patients with advanced colorectal carcinomaHeidi Schwarzenbach
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Int J Cancer 127:881-8. 2010..Our data provide insight into the molecular diversity of the regulation of the TS gene expression. This is the first study that compares multi-variant TS genotypes in different clinical specimens...
Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvementsImke Müller
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Germany
Clin Chem 54:688-96. 2008..However, plasma DNA may harbor tumor-specific genetic alterations and could therefore be an interesting target for noninvasive examinations of tumor DNA...
Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patientsUte Woelfle
Institute of Tumour Biology, Center of Experimental Medicine, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
J Immunol Methods 300:136-45. 2005..The method described offers an excellent tool for the enrichment of micrometastatic tumour cell clusters; these clusters may represent the initial stage of development from a single disseminated tumour cell towards an overt metastasis...
Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancerHeidi Schwarzenbach
Institut of Tumor Biology, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
Ann N Y Acad Sci 1022:25-32. 2004..Thus, screening for circulating tumor DNA may provide additional diagnostic information...
Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cellsBirthe Willipinski-Stapelfeldt
Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Clin Cancer Res 11:8006-14. 2005..This phenotypical change could already be detected in primary tumors and is associated with the aggressive behavior of breast cancer cells in vivo...
Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancerJussuf T Kaifi
Klinik fuer Allgemein, Viszeral und Thoraxchirurgie, Universitaetsklinikum Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
J Natl Cancer Inst 97:1840-7. 2005..We investigated CXCR4 expression in esophageal cancer specimens and its association with survival, lymph node microinvolvement, and bone marrow micrometastasis...
Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancerVolkmar Muller
Department of Gynecology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
Anticancer Res 26:1479-87. 2006..A soluble fragment of the epidermal growth factor receptor (EGFR) extracellular domain (sEGFR) can be detected in the serum of cancer patients, but the role of sEGFR is still unclear...
L1 is associated with micrometastatic spread and poor outcome in colorectal cancerJussuf T Kaifi
Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Mod Pathol 20:1183-90. 2007..It may have a role in early metastatic spread, as L1 is associated with micrometastases to both the lymph nodes and bone marrow. Thus, L1 should be explored further as a target for adjuvant therapy for micrometastatic disease...
Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patientsHeidi Schwarzenbach
Institute of Tumour Biology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, Hamburg, 20246, Germany
J Cancer Res Clin Oncol 137:811-9. 2011..MS-MLPA detects genetic and epigenetic aberrations of 37 tumor suppressor genes (TSG) in a single reaction and might, therefore, avoid the cumbersome single gene analyses...
Down-regulated expression of cytokeratin 18 promotes progression of human breast cancerUte Woelfle
Institute of Tumor Biology, University Hospital Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 10:2670-4. 2004..Cytokeratins (CKs) have been recognized for >20 years as structural marker proteins specific for epithelial cells. Recent expression profiling analyses indicate, however, that CK down-regulation may occur in breast cancer...
Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignanciesSusanna Hegewisch-Becker
Department of Oncology Hematology, University Hospital Hamburg Eppendorf, Hamburg D 20246, Germany
Clin Cancer Res 9:2079-84. 2003..Here we investigated whether the hyperdynamic state of the circulation as a consequence of WBH may stimulate dissemination of malignant cells...
Cancer micrometastasis and tumour dormancyHarriet Wikman
Institute of Tumour Biology, University Medical Center Hamburg Eppendorf, Germany
APMIS 116:754-70. 2008..e., cancer patient). In this review, we will summarize the key findings of research on micrometastatic cancer cells and discuss these findings in the context of the concept of tumour dormancy...
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletionMichaela Wrage
Institute of Tumor Biology and Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 15:1566-74. 2009..It is still unclear whether the shedding of DTC from the primary tumor is a random process or a selective release driven by a specific genomic pattern...
Microsatellite analysis in serum DNA as a diagnostic tool for distinction of patients with unknown pancreatic massesRobin Wachowiak
University Medical Center Hamburg Eppendorf, Hamburg, Germany
Diagn Mol Pathol 16:174-8. 2007..These data suggest that LOH analysis may be a substantial help for diagnosing pancreatic masses. An extension of the panel, perhaps in combination with a better selection of markers may further improve this assay...
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumorsOender Solakoglu
Molekulare Onkologie, , Hamburg, Germany
Proc Natl Acad Sci U S A 99:2246-51. 2002..006). In conclusion, the majority of cancer patients have viable tumor cells in their bone marrow at primary tumor diagnosis, and the proliferative potential of these cells determines the clinical outcome...
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral bloodNatalia Bednarz
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 16:3340-8. 2010..The present analysis was aimed to elucidate the biological and clinical roles of BRCA1 losses in metastatic spread and tumor progression in PCa patients...
Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasisSonja Loges
Department of Internal Medicine II, University Hospital Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 13:76-80. 2007..We compared MVD determination by immunohistology and quantitative real-time PCR and correlated the results with clinical variables...
Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterizationSabine Riethdorf
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Pathobiology 75:140-8. 2008..Furthermore, molecular characterization of CTCs might contribute to improving targeted and more individualized cancer therapies...
Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cellsAlice Hemsen
Institute for Tumor Biology, University Hospital Hamburg Eppendorf, Martinistrasse 52, D 20251 Hamburg, Germany
Int J Cancer 107:903-9. 2003..Our results indicate that uPAR plays an active role in breast cancer metastasis and may therefore be a promising target for new biologic therapies...
Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cellsFrank Wischnewski
Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
Mol Cancer Res 4:339-49. 2006..In conclusion, our data show for the first time that not only hypermethylation but also histone deacetylation is responsible for the mechanism underlying MAGE gene silencing...
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch systemSabine Riethdorf
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 13:920-8. 2007..Here, we validated the analytic performance of this system for clinical use in patients with metastatic breast cancer...
Disseminated tumor cells in breast cancer: detection, characterization and clinical relevanceUte Wölfle
University Medical Centre Hamburg Eppendorf, Institute of Tumor Biology, Martinistr 52, D 20246 Hamburg, Germany
Future Oncol 2:553-61. 2006....
Molecular signature associated with bone marrow micrometastasis in human breast cancerUte Woelfle
Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Germany
Cancer Res 63:5679-84. 2003..Thus, BM micrometastasis is a selective process with a specific molecular signature of the primary tumor...
Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promotersFrank Wischnewski
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Martinstrasse 52, 20246 Hamburg, Germany
Mol Cancer Res 5:749-59. 2007..In conclusion, these data show, for the first time, the involvement of methyl-CpG binding domain proteins in the regulation of the MAGE-A genes...
Micrometastasis in solid epithelial tumors: impact on surgical oncologyJakob R Izbicki
Department of Surgery, University Hospital Eppendorf, Hamburg, Germany
Surgery 131:1-5. 2002
Lymph node micrometastases in lung cancerKatharina E Effenberger
Institute of Tumor Biology, University Medical Center, Hamburg, Eppendorf, Germany
Cancer Treat Res 135:167-75. 2007
Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/ progenitor cell protein profileKai Bartkowiak
Institute for Tumor Biology, University Medical Center Hamburg Eppendorf Martinistr 52, 20246 Hamburg, Germany
J Proteome Res 8:2004-14. 2009..Hence, DTC from breast cancer patients' bone marrow expressed cytokeratin 5, which further supports our hypothesis...
Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancerSteven A Johnsen
Department of Molecular Oncology, Göttingen Center for Molecular Biosciences, University of Gottingen, Justus von Liebig Weg 11, 37077 Gottingen, Germany
Cancer Res 69:128-36. 2009..Combined, these results indicate that LIM cofactors CLIM and RLIM regulate the biological activity of ERalpha during the development of human breast cancer...
High incidence of EMMPRIN expression in human tumorsSabine Riethdorf
Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Int J Cancer 119:1800-10. 2006..Our results may assist in defining the suitability of EMMPRIN as therapeutic target and predicting negative side effects...
Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterusWolfgang Janni
Department of Gynecology and Obstetrics, I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
Cancer 97:405-11. 2003..This study evaluates the prevalence and prognostic significance of ITC in patients with primary carcinoma of the cervix uteri...
Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancerWulf Sienel
Department of Surgery, Chirurgische Klinik-Innenstadt, University of Munich, Munich, Germany
Int J Cancer 103:647-51. 2003..045). Thus, immunohistochemical evaluation of MMP-9 expression may provide a basis for the preselection of patients to be included in trials investigating specific protease inhibitor therapy after surgical resection of NSCLC...
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic diseasePeter Kufer
Institute of Immunology, University of Munich, 80336 Munich, Germany
Cancer Res 62:251-61. 2002..Because MAGE antigens can induce autologous cytolytic T lymphocytes in vivo, the determination of individual MAGE expression patterns in cancer patients may furthermore identify candidate vaccine targets for adjuvant immunotherapy...
Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patientsRainer Gangnus
, , , Germany
Clin Cancer Res 10:3457-64. 2004..Our preliminary results support the new concept that early disseminated cancer cells evolve independently from their primary tumor...
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrenceWolfgang Janni
I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
Cancer 103:884-91. 2005..If the persistence of ITCs after adjuvant therapy confers a similar risk for recurrence, then it would be an indication to consider secondary adjuvant therapy...
Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significanceWulf Sienel
Department of Surgery, Chirurgische Klinik und Poliklinik-Innenstadt, University of Munich, 80336 Munich, Germany
Eur J Cardiothorac Surg 23:451-6. 2003..Furthermore, in order to avoid an additional systemic spread of tumour cells intraoperatively, the pulmonary veins should be ligated first during lung cancer surgery...
Tumor cell dormancy: an NCI workshop reportRobert L Vessella
Department of Urology, University of Washington Medical Center and VA Puget Sound Health Care System, Seattle, Washington 98195, USA
Cancer Biol Ther 6:1496-504. 2007..The workshop concluded with an overall summary of the challenges and research opportunities associated with this field with recommendations for consideration by the NIH...
Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patientsJens Kollermann
Department of Urology, Universitatsklinikum Benjamin Franklin, Freie Universitat Berlin, Hindenburgdamm 30, 12200 Berlin, Germany
Eur Urol 44:533-8. 2003..To assess the feasibility of methylation-specific PCR (MSP) for the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) to detect occult prostate cancer cells in lymph nodes (LNs)...
A pooled analysis of bone marrow micrometastasis in breast cancerStephan Braun
Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria
N Engl J Med 353:793-802. 2005..We assessed the prognostic significance of the presence of micrometastasis in the bone marrow at the time of diagnosis of breast cancer by means of a pooled analysis...
Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potentialMenelaos Zafrakas
Heinrich Pette Institute for Experimental Virology and Immunology, University of Hamburg, 20251 Hamburg, Germany
Int J Mol Med 21:335-44. 2008..In conclusion, these data suggest that advanced ovarian endometriosis represents a highly differentiated tissue with minimal or no malignant potential...
Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapyHolger Thurm
Institute for Tumor Biology, University Hospital Hamburg-Eppendorf, D-20246 Hamburg, Germany
Clin Cancer Res 9:2598-604. 2003..Ep-CAM expression is, however, restricted to a subset of these cells, which may limit the broad applicability of Ep-CAM as target for second-line adjuvant therapy in breast cancer...
Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancerWulf Sienel
Department of Thoracic Surgery, Albert Ludwigs University Freiburg, Freiburg, Germany
Clin Cancer Res 13:3840-7. 2007..Thus far, the clinical relevance of MAGE-A transcripts as marker for disseminated tumor cells in bone marrow of patients with operable lung cancer without overt metastases is still unclear...
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapyStephan Braun
Department of Ob Gyn, University Hospital, Innsbruck, Austria
Breast 12:397-404. 2003..Except for promising pilot studies, no data are available to support the immediate use of bone marrow evaluation for treatment monitoring in order to enable the prediction of response to adjuvant therapy...
Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patientsBret Taback
Division of Surgical Oncology, Columbia University Medical Center, New York, New York 10032, USA
Ann N Y Acad Sci 1075:211-21. 2006..This study demonstrates the novel finding of tumor-associated epigenetic markers in BM aspirates/blood and their potential role as targets for molecular detection...
Current status in human breast cancer micrometastasisCatherine Alix Panabières
University Medical Center, Lapeyronie Hospital, Montpellier, France
Curr Opin Oncol 19:558-63. 2007..Current research and clinical developments on hematogeneous micrometastasis in breast cancer patients are summarized...
Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patientsDirk Schadendorf
Klinische Kooperationseinheit für Dermatoonkologie, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Mannheim, Germany
Exp Dermatol 12:165-71. 2003..Massive invasion of bone marrow with melanoma cells is a rare event even in far-advanced metastatic stages and no clear correlation between tumor load and bone marrow infiltration could be established...
